Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

INTRAMEDIC HOLDING A/S - Group Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Bankruptcy risk for industry   1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1%   Bankruptcy risk   1.4% 0.9% 3.4% 1.0% 0.6% 0.7% 4.9% 4.9%   Credit score (0-100)   80 90 53 86 96 93 44 44   Credit rating   A A BBB A AA AA BBB BBB   Credit limit (kDKK)   203.7 1,477.5 0.0 2,369.5 3,366.7 3,544.2 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   29,609 24,699 0.0 34,884 24,931 30,506 0.0 0.0   EBITDA   13,810 9,024 -16,396 17,604 7,341 11,885 0.0 0.0   EBIT   12,843 8,063 -17,391 16,601 6,340 10,707 0.0 0.0   Pre-tax profit (PTP)   12,598.8 7,751.3 -17,574.9 16,446.0 6,395.4 11,215.2 0.0 0.0   Net earnings   9,600.6 5,500.7 -17,574.9 12,676.2 4,638.7 8,516.4 0.0 0.0   Pre-tax profit without non-rec. items   12,599 7,751 -17,575 16,446 6,395 11,215 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Tangible assets total   17.8 200 172 163 179 108 0.0 0.0   Shareholders equity total   11,737 7,752 18,292 17,614 20,221 18,592 8,092 8,092   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   33,141 23,992 35,920 39,399 38,313 37,324 8,092 8,092   Net Debt   -5,537 -7,318 -16,465 -14,068 -15,292 -18,539 -6,210 -6,210     See the entire balance sheet 1000.0 Volume  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   29,609 24,699 0.0 34,884 24,931 30,506 0.0 0.0   Gross profit growth   8.3% -16.6% -100.0% 0.0% -28.5% 22.4% -100.0% 0.0%   Employees   22 23 25 25 25 26 0 0   Employee growth %   0.0% 4.5% 8.7% 0.0% 0.0% 4.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   33,141 23,992 35,920 39,399 38,313 37,324 8,092 8,092   Balance sheet change%   44.5% -27.6% 49.7% 9.7% -2.8% -2.6% -78.3% 0.0%   Added value   13,810.2 9,023.7 -16,395.9 17,603.7 7,342.1 11,885.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -1,935 -1,719 -1,964 -1,952 -1,926 -2,190 -108 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 -1.0 1.0 2.0 3.0 0.0 0.0   1000.0 Profitability  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   43.4% 32.6% 0.0% 47.6% 25.4% 35.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   46.4% 28.4% -58.1% 44.2% 16.8% 29.5% 0.0% 0.0%   ROI %   124.0% 80.6% -130.2% 92.5% 34.4% 57.4% 0.0% 0.0%   ROE %   91.7% 56.4% -135.0% 70.6% 24.5% 43.9% 0.0% 0.0%   1000.0 Solidity  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Equity ratio %   37.6% 36.0% 54.9% 44.7% 52.8% 49.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -40.1% -81.1% 100.4% -79.9% -208.3% -156.0% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Quick Ratio   1.2 1.1 1.9 1.5 1.7 1.6 0.0 0.0   Current Ratio   1.2 1.2 1.8 1.8 2.0 1.9 0.0 0.0   Cash and cash equivalent   5,537.2 7,318.0 16,464.6 14,067.6 15,292.4 18,539.0 0.0 0.0   1000.0 Capital use efficiency  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   5,136.3 2,498.5 13,487.6 15,423.3 17,258.6 16,559.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   628 392 -656 704 294 457 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   628 392 -656 704 294 457 0 0   EBIT / employee   584 351 -696 664 254 412 0 0   Net earnings / employee   436 239 -703 507 186 328 0 0